2021 ICD-10-CM Diagnosis Code D13.7

Benign neoplasm of endocrine pancreas

    2016 2017 2018 2019 2020 2021 Billable/Specific Code
  • D13.7 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2021 edition of ICD-10-CM D13.7 became effective on October 1, 2020.
  • This is the American ICD-10-CM version of D13.7 - other international versions of ICD-10 D13.7 may differ.
Applicable To
  • Islet cell tumor
  • Benign neoplasm of islets of Langerhans
Use Additional
Use Additional Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
  • code to identify any functional activity.
The following code(s) above D13.7 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D13.7:
  • C00-D49
    2021 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • D13
    ICD-10-CM Diagnosis Code D13

    Benign neoplasm of other and ill-defined parts of digestive system

      2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • benign stromal tumors of digestive system (D21.4)
    Benign neoplasm of other and ill-defined parts of digestive system
Approximate Synonyms
  • Benign (non-cancerous) glucagonoma
  • Benign glucagonoma
  • Benign islet cell tumor
  • Benign neoplasm of islets of langerhans
  • Benign neoplasm, insulinoma
  • Insulinoma
  • Nesidioblastoma
Clinical Information
  • A neoplasm with neuroendocrine differentiation that arises from the pancreas. It includes neuroendocrine tumors (low and intermediate grade) and neuroendocrine carcinomas (high grade).
ICD-10-CM D13.7 is grouped within Diagnostic Related Group(s) (MS-DRG v38.0):
  • 643 Endocrine disorders with mcc
  • 644 Endocrine disorders with cc
  • 645 Endocrine disorders without cc/mcc

Convert D13.7 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
Code annotations containing back-references to D13.7:
  • Type 1 Excludes: D13.6
    , D35
    ICD-10-CM Diagnosis Code D13.6

    Benign neoplasm of pancreas

      2016 2017 2018 2019 2020 2021 Billable/Specific Code
    Type 1 Excludes
    • benign neoplasm of endocrine pancreas (D13.7)
    ICD-10-CM Diagnosis Code D35

    Benign neoplasm of other and unspecified endocrine glands

      2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • benign neoplasm of endocrine pancreas (D13.7)
    • benign neoplasm of ovary (D27.-)
    • benign neoplasm of testis (D29.2.-)
    • benign neoplasm of thymus (D15.0)
    Use Additional
    • code to identify any functional activity
  • Type 2 Excludes: D3A
    , K86
    ICD-10-CM Diagnosis Code D3A

    Benign neuroendocrine tumors

      2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
    Code Also
    • any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
    Type 2 Excludes
    • benign pancreatic islet cell tumors (D13.7)
    Use Additional
    • code to identify any associated endocrine syndrome, such as:
    • carcinoid syndrome (E34.0)
    ICD-10-CM Diagnosis Code K86

    Other diseases of pancreas

      2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
    Type 2 Excludes
    • fibrocystic disease of pancreas (E84.-)
    • islet cell tumor (of pancreas) (D13.7)
    • pancreatic steatorrhea (K90.3)

Diagnosis Index entries containing back-references to D13.7:

ICD-10-CM Codes Adjacent To D13.7
D13 Benign neoplasm of other and ill-defined parts of digestive system
D13.0 Benign neoplasm of esophagus
D13.1 Benign neoplasm of stomach
D13.2 Benign neoplasm of duodenum
D13.3 Benign neoplasm of other and unspecified parts of small intestine
D13.30 Benign neoplasm of unspecified part of small intestine
D13.39 Benign neoplasm of other parts of small intestine
D13.4 Benign neoplasm of liver
D13.5 Benign neoplasm of extrahepatic bile ducts
D13.6 Benign neoplasm of pancreas
D13.7 Benign neoplasm of endocrine pancreas
D13.9 Benign neoplasm of ill-defined sites within the digestive system
D14 Benign neoplasm of middle ear and respiratory system
D14.0 Benign neoplasm of middle ear, nasal cavity and accessory sinuses
D14.1 Benign neoplasm of larynx
D14.2 Benign neoplasm of trachea
D14.3 Benign neoplasm of bronchus and lung
D14.30 Benign neoplasm of unspecified bronchus and lung
D14.31 Benign neoplasm of right bronchus and lung
D14.32 Benign neoplasm of left bronchus and lung
D14.4 Benign neoplasm of respiratory system, unspecified

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.